First Wave BioPharma, Inc. (FWBI) PT Lowered to $18 at Roth Capital
Tweet
Share
E-mailGet Alerts FWBI Hot Sheet
Price: $2.60 -8.45%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Roth Capital analyst Jonathan Aschoff lowered the price target on First Wave BioPharma, Inc. (NASDAQ: FWBI) to $18.00 (from $25.00) while maintaining a Buy rating.
You May Also Be Interested In
- Boralex Inc. (BLX:CN) (BRLXF) PT Lowered to Cdn$38 at CIBC
- Just Dial Ltd (JUST:IN) PT Raised to INR1,225 at UBS
- HDFC Asset Management Co Ltd (HDFCAMC:IN) PT Lowered to INR3,325 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
